PF-AtlasDrugs › Tai chi

Tai chi

Idiopathic Pulmonary Fibrosis

Clinical trials
1
Developer
London South Bank University

Overview

Tai chi is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.

Tai chi clinical trials

Explore related

Medical disclaimer. This page summarizes research about Tai chi for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.